“Lindus advances portfolios of in-licensed assets through our integrated clinical development platform, collaborating with biotech and pharma to take medicines further, faster.”In its own words: lindustx.com
Company originally founded as a technology-first clinical research organisation that now in-licenses and develops therapeutic assets. ARIA funded it under its Safeguarded AI programme.
Show detailsHide details
Received $151k from 1 funder
Led by Meri Beckwith (Co-Founder and Chief Executive Officer), Michael Young (Co-Founder)Checked 25 Oct 2026
Money flows
Where its money came from and where it went. Pick years and what to show; hover a box or ribbon for details, click one to focus it, click the background to see everything.
Funded by
All grants
1 grant totalling $151k, newest first.
2025 1 grant · $151k
| Date | Funder | Amount | Purpose |
|---|---|---|---|
| 26 Feb 2025 | Advanced Research + Invention Agency | $151k | Safeguarded AI TA3 (contract, 15 months); £119,189 incl. VAT; technical area inferred source |